LS
JUNO

Lupo Securities’s Juno Therapeutics, Inc. JUNO Stock Holding History

Lupo Securities’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$12K Buy
+300
New +$13.2K 0.09% 64

Other funds holding JUNO

CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GAMA
Graticule Asia Macro Advisors New York $649M AUM

Lupo Securities's JUNO Position: Q3 2015 in Review

Lupo Securities opened a new position in Juno Therapeutics, Inc. (JUNO) in Q3 2015: 300 shares worth $12K. The stake represents 0.09% of the portfolio and ranks #64 among its holdings.

132 funds tracked by Wall St. Rank hold JUNO as of Q3 2015.

  • Lupo Securities held 300 shares of Juno Therapeutics, Inc. worth $12K as of Q3 2015.
  • Juno Therapeutics, Inc. was a new Lupo Securities position in Q3 2015.
  • Juno Therapeutics, Inc. made up 0.09% of Lupo Securities's portfolio in Q3 2015, its #64 holding.
  • 132 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q3 2015.

Based on Lupo Securities's 13F filing for Q3 2015, filed 13 Nov 2015.